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Background/Aims: Hypoalbuminemia occurs frequently in renal transplant recipients immediately after renal 
transplantation. We studied the regulation of hepatic albumin synthesis by cyclosporin A (CsA) in Huh7 cells.
Methods: Huh7 cells were incubated with various concentrations of CsA for 4, 8, 16, and 24 hours. Albumin was 
measured in Huh7 cell-conditioned medium by sandwich enzyme-linked immunosorbent assay and Western blot. Albumin 
mRNA expression was analyzed by Northern blotting in CsA-treated cells. 
Results: CsA (10
-7-10
-4 M) inhibited albumin synthesis in Huh7 cells in a dose- dependent manner. A Western blot analysis 
for albumin in the conditioned medium released from CsA-treated (10
-7-10
-5 M) cells also showed significant inhibition of 
albumin synthesis in a dose-dependent manner. Vehicle (olive oil) did not affect albumin synthesis. In contrast, a Northern 
blot analysis revealed no inhibition of albumin mRNA expression by CsA at any time point from 1-24 hours, indicating that 
the inhibition of albumin synthesis occurred at the translational level. 
Conclusions: Our results suggest that inhibition of hepatic albumin synthesis by high dose CsA contributes to the 
hypoalbuminemia in renal transplant recipients.
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INTRODUCTION 
Hypoalbuminemia occurs frequently during the early 
post-renal transplantation period in renal transplant re-
cipients. Hypoalbuminemia, followed by low intravascular 
volume, delays the onset of urine output, decreases urine 
volume, delays recovery of renal function, and increases 
the rate of delayed graft function [1]. Patients undergoing 
various surgical procedures show transient hypoalbumin-
emia that occurs during the early post-operative period 
(usually within the first week) [2,3]. In contrast, we have 
experienced long-lasting, noticeable hypoalbuminemia, 
often associated with decreased urine output, slowly re-
covering or even worsening renal function that was ini-
tially recovering, and ascites formation in renal transplant 
recipients during the early post-operative period. 
In a retrospective analysis of 200 renal transplant re-
cipients at our center, serum albumin levels decreased by 
more than 0.5 g/dL in 44% of recipients during the first 
month after the operation. The lowest serum albumin lev-
els were observed at post-operative day 14, which recov-
ered to pre-operative levels at 60 days after the operation. 
We have also observed that an albumin infusion recovers 
urine output and renal function very quickly in cases of 
hypoalbuminemia-induced renal dysfunction. 
Hypoalbuminemia generally results from decreased 
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hepatic synthesis, increased catabolism, protein loss 
from the intravascular space, or plasma dilution. Protein 
loss could not explain the hypoalbuminemia in our 
transplant recipients, because most of our recipients 
were orally fed for 2 days, and losses in wound drainage 
were minimal. We found no correlation between changes 
in serum albumin levels and changes in body weight, 
indicating that plasma dilution was not the cause for the 
hypoalbuminemia. 
High-dose cyclosporin A (CsA) is routinely administered 
to renal transplant recipients during the early post-
operative period, and this drug is well known to be 
hepatotoxic and to regulate hepatic enzymes including 
cytochrome P450. CsA inhibits hepatic protein synthesis, 
probably at the translation level, based on in vitro and in 
vivo experiments [4-6]. However, it has not been clearly 
determined if CsA regulates hepatic albumin synthesis. 
In this study, we examined albumin gene expression in 
a CsA-treated human hepatoma cell line, Huh7 cells, and 
measured albumin in the conditioned medium released 
from CsA-treated cells and albumin gene expression in the 
same cells.
METHODS
Cell culture 
Huh7 cells, a human hepatoma cell line, were main-
tained in Modified Eagle’s medium (MEM) supplemented 
with 10% heat inactivated fetal bovine serum and an anti-
biotic/antifungal solution. Cell cultures were maintained 
at 37°C under 5% CO2. All cell culture materials were pur-
chased from Gibco BRL (Gaithersburg, MD, USA).
Enzyme-linked immunosorbent assay
Albumin in the conditioned medium released from 
Huh7 cells was measured by a sandwich enzyme-linked 
immunosorbent assay (ELISA). To observe the dose 
response of CsA (Sandoz, Seoul, Korea) to albumin 
synthesis, the cells were plated in six-well dishes, grown 
to confluence, and incubated in 1 mL of fresh serum-
free MEM medium with or without various doses of 
CsA. After 24 hours, the conditioned medium was 
collected, centrifuged at 10,000 × g (4°C) for 3 minutes, 
and stored at -70°C until assay. For the albumin ELISA, 
rabbit anti-human albumin antibody (1:4,000) (DAKO, 
Glostrup, Denmark) was used as the capture antibody and 
horseradish peroxidase-conjugated rabbit anti-human 
albumin antibody (1:2,000) (DAKO) was used as the 
detection antibody. O-Phenylenediamine dihydrochloride 
(Gibco BRL) was used as the enzyme substrate, and 
human serum albumin (Green Cross Corp., Seoul, Korea) 
was used as the standard.
Western blot analysis
Confluent Huh7 cells, plated in six-well dishes, were 
incubated in 1 mL of fresh serum-free medium with 
or without various doses of CsA for 24 hours, and the 
medium was collected. The conditioned medium was 
centrifuged at 16,000 × g for 15 minutes at 4°C, and 
protein concentration of the conditioned medium was 
determined using the Bradford protein bioassay (Bio-
Rad, Hercules, CA, USA). The conditioned medium was 
heated at 94°C for 5 minutes in sample buffer. Proteins 
were separated by SDS-PAGE on 7.5% polyacrylamide 
gels and were electroblotted onto a Bio-Blot nitrocellulose 
membrane (Costar, Cambridge, MA, USA). Nonspecific 
binding was blocked by incubating the blots for 1 hour 
in 5% (w/v) nonfat milk. Albumin was detected by an 
overnight incubation with a rabbit anti-human albumin 
antibody (1:1,000). The primary antibody incubation was 
followed by six washes in Tris-buffered saline with 0.005% 
Tween20. The blot was then incubated with horseradish 
peroxidase-conjugated anti-rabbit IgG (Amersham Life 
Science, Little Chalfont, UK) at 1:2,000 for 30 minutes. 
Antibody reactive protein was detected using enhanced 
chemiluminescence (Amersham Life Science).
RNA Isolation and Northern blot analysis
Confluent Huh7 cells, plated in 10 cm dishes, were 
inc ubated in 4 mL of fresh serum-free medium with or 
without various doses of CsA for 24 hours to test the effect 
of CsA on albumin gene expression. For the time course, 
cells were incubated with or without CsA (10
-6 M) for 
the indicated time points. RNA was isolated by one-step 
guanidium-thiocyanate-phenol-chloroform extraction. 
RNA concentration was measured by absorbance at 260 
nm. RNA quantification and integrity were confirmed 
by 1% agarose gel electrophoresis and ethidium bromide 
staining. Total RNA was fractionated by electrophoresis 
on a 1% agarose-formaldehyde gel and blotted by capillary 
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Boston, MA, USA) and cross-linked with UV irradiation 
(UV Strata-linker1800, Stratagene, Cedar Creek, TX, 
USA). The membrane was probed with human albumin 
cDNA (ATCC# 59713, 1.0 kb) labeled by random priming 
using a commercial kit (Amersham Life Science) and [32
P]
dCTP. The blot was prehybridized at 42°C for 2 hours in 
50% formamide, 0.1% SDS, 2 × Denhardt’s solution, 5 × 
SSPE, and 0.1 mg/mL salmon sperm DNA. Probe (10
6 
cpm/mL) was added to the prehybridization solution, and 
the blot was hybridized for 16 hours at 42°C. The blot was 
then washed twice for 15 minutes at 55°C in 2 × standard 
saline citrate and 0.1% SDS, and autoradiography was 
performed with Fuji X-ray film and an intensifying screen 
at -70°C. The albumin probe was then removed by boiling, 
and the same blot was rehybridized to a cDNA probe 
encoding the 36B4 ribosomal protein. Densitometric 
analysis was used to detect the intensity of the albumin 
and 36B4 signals.
Statistical analysis
Statistical comparisons between multiple groups were 
performed with an analysis of variance, and Bonferroni’s 
method was applied to control for multiple testing. A p   
value < 0.05 was considered statistically significant.
RESULTS
Albumin synthesis in Huh7 cells 
Confluent Huh7 cells incubated for 24 hours secreted 
large amounts of albumin (5.18 ± 0.49 µg/mL). CsA 
significantly decreased the albumin release in a dose-
dependent manner (p < 0.01). Vehicle (olive oil) did not 
affect the albumin concentration in conditioned medium. 
CsA inhibited albumin synthesis by 48%, 60% and 82% at 
concentrations of 10
-6 M, 10
-5 M, and 10
-4 M, respectively 
(Fig. 1A). The inhibition of albumin synthesis by CsA was 
statistically significant at 24 hours (Fig. 1B). A Western 
blot analysis for albumin in the conditioned medium 
released from Huh7 cells also revealed that CsA inhibited 
albumin synthesis in a dose-dependent manner at doses 
from 10
-7 M to 10
-5 M, whereas the vehicle did not (Fig. 1C).
Cell viability
Cell viability was tested by staining the cells from each 
Figure 1. Albumin concentration in the conditioned medium 
was measured in untreated- and cyclosporine A (CsA)-treated 
Huh7 cells. (A) Confluent cells were incubated with or without 
various doses of CsA for 24 hours. (B) The confluent cells 
were incubated with or without CsA (10
-6 M) for the indicated 
time periods, and albumin was measured by enzyme-linked 
immunosorbent assay (ELISA). Olive oil was used as a vehicle. 
Data are expressed as mean ± SE. Values are means of four 
independent experiments performed in duplicate samples. 
*p < 
0.01 vs. control. (C) Western blot analysis for albumin in Huh7-
cell conditioned medium. The cells were incubated with or 
without various doses of CsA for 24 hours. Numbers on the left 
represent sizes in kilodaltons. Olive oil was used as a vehicle. 
Densitometric values are the mean of two experiments and are 
expressed as mean ± SE.
A
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experiment with trypan blue. More than 95% of cells 
treated with various concentrations of CsA were viable.
Albumin gene expression 
The Northern blot analysis revealed that CsA (10
-7-10
-5 M) 
did not inhibit albumin mRNA expression in Huh7 cells 
after a 24 hours incubation (Fig. 2A). In the time course, 
albumin mRNA expression in the untreated cells peaked 
between 2 and 4 hours and then decreased gradually un-
til 24 hours. However, no difference in albumin mRNA 
expression was observed at any time point from 1 to 24 
hours between untreated and CsA-treated Huh7 cells, 
indicating that inhibition of albumin synthesis by CsA 
occurred at the translational level (Fig. 2B). 
DISCUSSION 
The principal finding of this study was that CsA inhib-
ited translation of albumin synthesis in Huh7 cells. A spe-
cial synthetic assembly line for the synthesis of proteins 
for export, including serum albumin, is present within 
hepatocytes. After DNA-directed specific RNA synthesis, 
the protein production process proceeds in the cytoplasm. 
The ribosome consists of two subunits, a smaller unit (40-
S) and a larger unit (60-S). The smaller subunit is attached 
to mRNA, whereas the larger subunit is attached to the 
microtubular structure, the endoplasmic reticulum. As the 
albumin molecule is synthesized, it is inserted through the 
center of the larger subunit into the endoplasmic reticu-
lum, and is then extruded into the hepatic plasma by tra-
versing both the smooth endoplasmic reticulum and Golgi 
apparatus [7-9]. 
Huh7 cells have been used for biological assays and are 
known to secrete many endogenous proteins, including 
α-fetoprotein, β2-microgloblin, integrins and transferring 
[10-13]. Confluent Huh7 cells secreted a large amount of 
albumin, which accumulated continuously up to 48 hours. 
Our finding of a decreased amount of albumin in the con-
ditioned medium released from CsA-treated Huh7 cells, 
without decreased albumin mRNA expression, indicates 
that CsA inhibits translation of albumin synthesis at the 
ribosome. The Western blot analysis of albumin from the 
conditioned medium also revealed that CsA inhibited 
albumin synthesis. However, further study is needed to 
compare albumin production between Huh7 cell lysates 
and conditioned medium, which would verify whether CsA 
blocks albumin secretion from the cytoplasm into condi-
tioned medium.
CsA is hepatotoxic including inhibition of hepatic pro-
tein synthesis. CsA administered orally (100 mg/kg/day) 
to rats for 21 days causes marked decreases in total serum 
protein and albumin, accompanied by rises in alkaline 
phosphatase and total bilirubin. A morphological exami-
nation of the liver revealed moderate centrilobular fatty 
changes and minor dilatation of endoplasmic reticulum 
[14]. In our experiments, more than 95% of Huh7 cells 
treated with CsA were viable. Inhibition of hepatic 
Figure 2. Northern blot analysis for albumin gene expression 
in Huh7 cells. (A) The confluent cells were incubated with or 
without various doses of cyclosporine A (CsA) for 24 hours, and 
total RNA was isolated. (B) Confluent cells were incubated with 
or without CsA (10
-6 M). Total RNA was isolated after 1, 2, 4, 8, 16, 
and 24 hours. The figures in both (A) and (B) are representative 
of three experiments. Densitometric values are the mean of three 
experiments, and are expressed as mean ± SE.
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albumin synthesis by CsA may occur independently of 
hepatotoxicity.
We also measured transferrin in the conditioned 
medium by direct ELISA, which is a protein typically 
produced in the liver. CsA significantly inhibited 
transferrin synthesis at 10
-7 M and higher doses in a dose-
dependent manner (data not shown). It is likely that CsA 
inhibits not only albumin synthesis but also synthesis 
of other proteins produced in the liver. A previous study 
showed that both albumin and transferrin levels were 
reduced in the supernatant treated with CsA [15]. Albumin 
and transferrin are negative acute-phase proteins that are 
excellent markers of mortality risk in patients with end-
stage renal disease [16,17] and may contribute to mortality 
after kidney transplantation. 
In many transplant centers, including ours, the CsA 
whole-blood trough level target during early renal 
transplantation period is approximately 400 ng/mL, 
which accounts for 3 × 10
-7 M. In an animal study, CsA 
concentration in liver tissue was 9.5 times higher than 
that in blood [18]. Therefore, when the whole-blood trough 
level is 3 × 10
-7 M, the concentration in liver tissue may 
approach 2.85 × 10
-6 M. Furthermore, peak levels of CsA 
in blood are five times higher than trough levels. In this 
study, CsA significantly inhibited albumin synthesis in 
Huh7 cells at 10
-6 M or higher concentrations, which could 
be the liver tissue exposure level in transplant recipients. 
In all patients with post-transplant hypoalbuminemia, 
serum albumin levels increase gradually as CsA dose 
is serially reduced. This clinical finding seems to be 
associated with the observation that CsA-induced 
hepatotoxicity, including hypoalbuminemia, improves 
when CsA concentration in liver tissue is < 10
-6 M.
Several studies have reported on the effect of tacrolimus 
(FK-506) and CsA on albumin secretion. In one study, FK-
506 did not influence albumin secretion, but CsA mildly 
inhibited albumin production in HepG2 cells. That study 
also showed that FK-506 but not CsA attenuated the 
inhibitory effect of interleukin-6 on albumin secretion 
[19]. Another study comparing a different effect of CsA 
and FK-506 on hepatic albumin secretion revealed that 
albumin and transferrin production in CsA-treated cells 
decreased significantly compared to that in solvent or FK-
506-treated cells [15]. Although CsA and FK-506 share the 
same mechanism of action in downregulating cytokines 
by inhibiting calcineurin, we assume that the inhibitory 
effect of CsA on albumin hepatic synthesis may not be 
through calcineurin inhibition. 
The mechanisms and sites of albumin degradation 
have not been identified yet. The kidney has been shown 
not to play a significant role in albumin degradation in 
the normal state, but may play an active role in disease 
states. In a rat model of nephrotic syndrome, a bilateral 
nephrectomy decreases the absolute albumin catabolic 
rate by about 50%. In the normal condition, small 
amounts of albumin, which traverse the glomerular filter, 
are catabolized by tubular cells. Electron microscopy 
has revealed albumin transport across the convoluted 
and proximal straight segments of the tubule [20-22]. 
However, it must be determined if albumin catabolism 
in the kidney increases following the administration of 
immunosuppressive agents or by transplantation surgery 
itself.
In conclusion, our results provide evidence that high-
dose CsA inhibits hepatic albumin synthesis at the level 
of translation, which is a mechanism for CsA-induced 
hepatotoxicity and might be a cause of hypoalbuminemia 
in renal transplant recipients during the early post-
transplantation period. CsA-induced hypoalbuminemia 
needs to be included in the differential diagnosis of early 
acute renal dysfunction in renal transplant recipients.
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